---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-18T20:25:39.666706'
end_time: '2026-01-18T20:33:54.331414'
duration_seconds: 494.66
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: BCAP31
  gene_symbol: BCAP31
  uniprot_accession: P51572
  protein_description: 'RecName: Full=B-cell receptor-associated protein 31; Short=BCR-associated
    protein 31; Short=Bap31; AltName: Full=6C6-AG tumor-associated antigen; AltName:
    Full=Protein CDM; AltName: Full=p28;'
  gene_info: Name=BCAP31 {ECO:0000312|HGNC:HGNC:16695}; Synonyms=BAP31 {ECO:0000303|PubMed:25854864},
    DXS1357E;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the BCAP29/BCAP31 family. .
  protein_domains: BAP29/BAP31. (IPR008417); BAP29/BAP31_N. (IPR040463); Bap31/Bap29_C.
    (IPR041672); Bap31 (PF05529); Bap31_Bap29_C (PF18035)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 10
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P51572
- **Protein Description:** RecName: Full=B-cell receptor-associated protein 31; Short=BCR-associated protein 31; Short=Bap31; AltName: Full=6C6-AG tumor-associated antigen; AltName: Full=Protein CDM; AltName: Full=p28;
- **Gene Information:** Name=BCAP31 {ECO:0000312|HGNC:HGNC:16695}; Synonyms=BAP31 {ECO:0000303|PubMed:25854864}, DXS1357E;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the BCAP29/BCAP31 family. .
- **Key Domains:** BAP29/BAP31. (IPR008417); BAP29/BAP31_N. (IPR040463); Bap31/Bap29_C. (IPR041672); Bap31 (PF05529); Bap31_Bap29_C (PF18035)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "BCAP31" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'BCAP31' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **BCAP31** (gene ID: BCAP31, UniProt: P51572) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P51572
- **Protein Description:** RecName: Full=B-cell receptor-associated protein 31; Short=BCR-associated protein 31; Short=Bap31; AltName: Full=6C6-AG tumor-associated antigen; AltName: Full=Protein CDM; AltName: Full=p28;
- **Gene Information:** Name=BCAP31 {ECO:0000312|HGNC:HGNC:16695}; Synonyms=BAP31 {ECO:0000303|PubMed:25854864}, DXS1357E;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the BCAP29/BCAP31 family. .
- **Key Domains:** BAP29/BAP31. (IPR008417); BAP29/BAP31_N. (IPR040463); Bap31/Bap29_C. (IPR041672); Bap31 (PF05529); Bap31_Bap29_C (PF18035)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "BCAP31" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'BCAP31' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **BCAP31** (gene ID: BCAP31, UniProt: P51572) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan overview
- Verified identity: Human BCAP31 (Bap31), UniProt P51572, ER-resident polytopic membrane protein in the BCAP29/BCAP31 family; literature aligns with ER cargo control and apoptosis signaling roles (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135).
- Collected evidence on localization/topology, cargo selection and MHC I, ER quality control/ERAD, ER–mitochondria contacts and apoptosis signaling, disease associations (DDCH/Schimke XLID), and expression.
- Prioritized recent/authoritative studies and included URLs where available.

Comprehensive research report: BCAP31 (Bap31), human (UniProt P51572)

1) Key concepts and definitions with current understanding
- Identity and family. BCAP31 encodes Bap31, an abundant endoplasmic reticulum (ER) integral membrane protein belonging to the BCAP29/BCAP31 family; it forms homo/hetero-oligomers with Bap29 and participates in quality control and trafficking of multi-pass membrane proteins at the ER (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135).
- ER localization and topology. Bap31 is a polytopic ER protein with three N-terminal transmembrane helices and a cytosolic C-terminal domain that includes a coiled-coil and a KKXX ER-retrieval motif; it resides in peripheral ER and cycles to a juxtanuclear ER quality-control (ERQC) compartment functionally linked to ER-associated degradation (ERAD) (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135, louie2020schimkexlidsyndrome pages 6-7).
- Core molecular roles. Bap31 acts as a selective cargo receptor/chaperone for multi-pass membrane proteins, coordinates ER export/quality control, and is a key node for ER–mitochondria crosstalk in apoptosis and mitochondrial homeostasis (stojanovic2006rolebap31complex pages 131-135, stojanovic2006rolebap31complex pages 66-72, namba2019bap31regulatesmitochondrial pages 2-3).

2) Recent developments and latest research (emphasis 2023–2024 where available)
- MERCs and mitochondrial regulation. A high-impact study established that Bap31 directly engages the mitochondrial TOM complex (Tom40) at ER–mitochondria contact sites to promote import of NDUFS4 and integrity of complex I; loss of Bap31 reduces mitochondrial membrane potential and shifts cells toward AMPK–ULK–LC3 autophagy without activating canonical ER-stress branches, highlighting a MERC-centered role in mitochondrial homeostasis (Science Advances, 2019; URL: https://doi.org/10.1126/sciadv.aaw1386) (namba2019bap31regulatesmitochondrial pages 2-3).
- Clinical genetics refinement. BCAP31 loss-of-function has been causally linked to an X-linked neurodevelopmental disorder with deafness, dystonia, and central hypomyelination (DDCH), and to the historically described Schimke XLID; recent clinical syntheses confirm that Schimke XLID and DDCH reflect the same BCAP31-related syndrome (AJMG Part A, 2020; URL: https://doi.org/10.1002/ajmg.a.61755) (louie2020schimkexlidsyndrome pages 6-7). Earlier case series defined multiple pathogenic alleles and established Golgi disorganization and ER/Golgi trafficking defects in patient fibroblasts (AJHG, 2013; URL: https://doi.org/10.1016/j.ajhg.2013.07.023) (cacciagli2013mutationsinbcap31 pages 1-2, cacciagli2013mutationsinbcap31 pages 4-6).
- Apoptosis signaling mechanistic updates (still foundational). ER-resident Bap31 is an early substrate of caspase-8; its p20 fragment causes ER Ca2+ release, mitochondrial Drp1 recruitment and fission, and sensitizes mitochondria for cytochrome c release, mechanistically linking death receptor signaling to ER–mitochondria crosstalk (J Cell Biol, 2003; URL: https://doi.org/10.1083/jcb.200212059) (stojanovic2006rolebap31complex pages 66-72).

3) Current applications and real-world implementations
- Diagnostic genetics. Recognition that BCAP31 pathogenic variants cause DDCH/Schimke XLID informs clinical testing panels for early-onset deafness with dystonia and white matter hypomyelination; segregation and variant interpretation have leveraged fibroblast phenotypes (Golgi disorganization, ERAD defects) as supportive functional evidence (AJHG, 2013; AJMG A, 2020) (cacciagli2013mutationsinbcap31 pages 1-2, cacciagli2013mutationsinbcap31 pages 4-6, louie2020schimkexlidsyndrome pages 6-7).
- Cell biology models. Mechanistic assays commonly use: (a) ER export/trafficking readouts for tetraspanins and MHC I; (b) ERAD models (e.g., ΔF508-CFTR) and analysis of Sec61 interactions; (c) MERC assays and mitochondrial function (ΔΨm, complex I assembly) to interrogate Bap31 function (The Journal of Immunology, 2006; Science Advances, 2019) (stojanovic2006rolebap31complex pages 26-31, namba2019bap31regulatesmitochondrial pages 2-3).

4) Expert opinions and analysis from authoritative sources
- ER cargo selection and ERQC. Consolidated analyses place Bap31 at the ribosome–Sec61 translocon and in large complexes (200 kDa–3 MDa) with classical ER chaperones, supporting a role in co-/post-translational triage, favoring export of properly assembled multi-pass proteins while retaining or routing aberrant clients to ERAD (reviewed/compiled in 2006) (stojanovic2006rolebap31complex pages 131-135, stojanovic2006rolebap31complex pages 17-21).
- MHC class I trafficking. Bap31 enhances ER export and quality control of human MHC I, consistent with a role in immune antigen presentation pathways and providing a client class for its cargo receptor function (The Journal of Immunology, 2006) (stojanovic2006rolebap31complex pages 26-31).
- ER–mitochondria integration. The emergence of Bap31 as a MERC component that coordinates mitochondrial protein import (Tom40 interaction) reframes its function from an ER-only chaperone to an inter-organelle regulator, rationalizing the neurological vulnerability in BCAP31 syndrome via defective energy metabolism and organelle crosstalk (Science Advances, 2019) (namba2019bap31regulatesmitochondrial pages 2-3).

5) Relevant statistics and data from recent and foundational studies
- Disease cohorts. In a landmark series, seven affected males from three families carried distinct BCAP31 loss-of-function variants, all presenting with intellectual disability, dystonia, sensorineural deafness, and hypomyelinating white-matter changes; patient fibroblasts showed disorganized Golgi, altered ER morphology, reduced ERAD capacity (ΔF508-CFTR accumulation), and no constitutive UPR activation (AJHG, 2013; URL: https://doi.org/10.1016/j.ajhg.2013.07.023) (cacciagli2013mutationsinbcap31 pages 1-2, cacciagli2013mutationsinbcap31 pages 4-6).
- Mitochondrial function metrics. Bap31 knockdown reduces mitochondrial membrane potential (JC-1 assays) and decreases complex I activity via impaired NDUFS4 import; it increases LC3-II flux and Parkin relocalization, indicating altered mitophagy signaling (Science Advances, 2019; URL: https://doi.org/10.1126/sciadv.aaw1386) (namba2019bap31regulatesmitochondrial pages 2-3).
- Trafficking readouts. Manipulating Bap31 or expressing its p20 fragment reduces surface expression of client tetraspanins and perturbs adhesion, consistent with cargo-selective ER export control (reviewed/compiled from experimental work) (stojanovic2006rolebap31complex pages 66-72).

Functional, mechanistic, and pathway narrative
- ER localization and topology. Bap31 is a three-pass membrane protein of the ER; its cytosolic C-terminus contains a coiled-coil and KKXX motif for COPI-mediated ER retrieval. It localizes at the peripheral ER and a juxtanuclear ERQC compartment associated with ERAD (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135, louie2020schimkexlidsyndrome pages 6-7).
- Cargo selection/ER export and MHC class I. Bap31 binds selective multi-pass cargos (e.g., tetraspanins) and promotes their exit from the ER; it enhances the ER export and quality control of human MHC class I, linking to antigen presentation and demonstrating client specificity in export assistance (The Journal of Immunology, 2006; URL: https://doi.org/10.4049/jimmunol.177.9.6172) (stojanovic2006rolebap31complex pages 26-31, stojanovic2006rolebap31complex pages 131-135, stojanovic2006rolebap31complex pages 66-72).
- ERQC/ERAD and ERQC compartment. Bap31 associates with Sec61 and classical chaperones, consistent with roles at the translocon in folding surveillance and retrotranslocation; patient cells with BCAP31 loss show ΔF508-CFTR accumulation (reduced ERAD) and Golgi disorganization, strengthening its functional positioning at the ERQC–ER–Golgi interface (AJHG, 2013; URL: https://doi.org/10.1016/j.ajhg.2013.07.023) (stojanovic2006rolebap31complex pages 131-135, cacciagli2013mutationsinbcap31 pages 4-6, cacciagli2013mutationsinbcap31 pages 1-2).
- ER–mitochondria contact sites and apoptotic signaling. Bap31 forms a bridge with mitochondrial Tom40 at MERCs to support NDUFS4 import and complex I function, thereby sustaining mitochondrial bioenergetics; during death receptor signaling, caspase-8 cleaves Bap31 to p20, which elicits ER Ca2+ release, Drp1 recruitment to mitochondria, mitochondrial fission, and potentiation of cytochrome c release, integrating MERC structure with apoptotic signaling dynamics (Science Advances, 2019; J Cell Biol, 2003) (namba2019bap31regulatesmitochondrial pages 2-3, stojanovic2006rolebap31complex pages 66-72).
- Disease associations and phenotypes. Hemizygous pathogenic variants in BCAP31 cause an X-linked neurodevelopmental syndrome characterized by deafness, dystonia, and central hypomyelination (DDCH), historically termed Schimke XLID; genetic reports and case re-evaluations demonstrate that these are the same entity attributable to BCAP31 loss, with mechanistic links to ER/Golgi trafficking and organelle crosstalk defects (AJHG, 2013; AJMG A, 2020) (cacciagli2013mutationsinbcap31 pages 1-2, louie2020schimkexlidsyndrome pages 6-7).
- Expression. Bap31 is broadly expressed and notably abundant in neurons; neurological enrichment aligns with the clinical phenotype in BCAP31-related disease and with its MERC/mitochondrial regulatory roles (AJHG, 2013) (cacciagli2013mutationsinbcap31 pages 1-2).

Embedded evidence summary
| Topic/Claim | Key Evidence / Details | Primary Source (authors, year) | Journal / Type | URL | Notes |
|---|---|---|---|---|---|
| ER localization & topology | Polytopic ER-resident membrane protein with three transmembrane domains, cytosolic C‑terminal coiled-coil and KKXX retrieval motif; localizes to peripheral ER and juxtanuclear ER/ERQC compartments (biochemistry, co-IP, microscopy). (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135) | Stojanovic M., 2006 | Review/experimental summary | — | Topology inferred from sequence + biochemical localization (human and mammalian cells). |
| Cargo selection & MHC I trafficking | Functions as an ER chaperone/cargo receptor that selectively promotes ER export of subsets of multi-pass membrane proteins (e.g., tetraspanins) and influences MHC class I export/quality control. (stojanovic2006rolebap31complex pages 131-135, stojanovic2006rolebap31complex pages 66-72) | Stojanovic M., 2006 (experimental data) | Review/experimental | — | Evidence: knockdown/fragment (p20) perturb trafficking and cell-surface levels of client proteins. |
| ERAD / ER quality control (juxtanuclear QC) | Interacts with Sec61/translocon and classical ER chaperones; implicated in retrotranslocation and ERAD of misfolded membrane proteins; patient cells show reduced ERAD (ΔF508-CFTR accumulation) and Golgi disorganization when BCAP31 is lost. (stojanovic2006rolebap31complex pages 131-135, cacciagli2013mutationsinbcap31 pages 4-6, cacciagli2013mutationsinbcap31 pages 1-2) | Stojanovic M., 2006; Cacciagli et al., 2013 | Experimental / clinical genetics | https://doi.org/10.1016/j.ajhg.2013.07.023 (Cacciagli 2013) | Methods: co-IP, overexpression/knockdown, patient fibroblast assays (human). |
| ER–mitochondria contacts; interactors (Tom40, Fis1, CDIP1); caspase-8 cleavage → p20 → Ca2+ signaling & apoptosis | BAP31 forms an ER–mitochondria bridging complex with TOM40 to regulate mitochondrial complex I assembly and mitochondrial function; caspase-8 cleavage generates p20 fragment that triggers ER Ca2+ release, Drp1 recruitment/mitochondrial fission, and potentiation of cytochrome c release/apoptosis. (namba2019bap31regulatesmitochondrial pages 2-3, stojanovic2006rolebap31complex pages 66-72) | Namba T., 2019; Stojanovic / Breckenridge data summarized 2003/2006 | Science Advances (Namba 2019); review/experimental (apoptosis studies) | https://doi.org/10.1126/sciadv.aaw1386 (Namba 2019) | Tom40 interaction experimentally shown (Namba 2019). Caspase‑cleavage → p20 and Ca2+ transfer mechanisms described in apoptosis studies (ER→mitochondria signaling). |
| Disease associations: DDCH / Schimke XLID (BCAP31 pathogenic variants) | Hemizygous loss-of-function BCAP31 alleles cause X-linked syndrome with sensorineural deafness, dystonia, central hypomyelination (white-matter changes) and Golgi/ER disorganization; clinical case series and genotype-phenotype description. (cacciagli2013mutationsinbcap31 pages 1-2, louie2020schimkexlidsyndrome pages 6-7) | Cacciagli et al., 2013; Louie et al., 2020 | American Journal of Human Genetics; AJMG Part A (clinical reports) | https://doi.org/10.1016/j.ajhg.2013.07.023 (Cacciagli 2013), https://doi.org/10.1002/ajmg.a.61755 (Louie 2020) | Clinical phenotypes defined (DDCH = deafness, dystonia, central hypomyelination); molecular lesions include truncations, deletions, splice variants. |
| Neuronal / endocrine expression | BAP31 is highly expressed in neurons and discrete endocrine cells; CNS vulnerability evidenced by neurological phenotypes in patients and by expression patterns. (cacciagli2013mutationsinbcap31 pages 1-2) | Cacciagli et al., 2013 | Experimental / clinical | https://doi.org/10.1016/j.ajhg.2013.07.023 (Cacciagli 2013) | Expression data + patient phenotypes (human). Additional histochemistry studies referenced in broader literature. |
| 2023–2024 reviews / recent literature status | Searches identified 2023–2024 reviews and 2024 articles discussing MERCs and BAP31, but full text / recent-review content was not retrievable within the current evidence set; targeted retrieval recommended for Makio 2024, Dong 2024, Bonati 2024 and other 2024 MERC reviews. | Search logs / aggregated results (2024) | Literature search result note | — | Indicates need to fetch full texts of 2023–2024 reviews for the latest syntheses and clinical-report updates. |


*Table: A concise table mapping major functional claims about human BCAP31 (BAP31, UniProt P51572) to supporting experimental and clinical sources (context IDs shown) and providing URLs where available; useful for rapid cross-checking of evidence and planning deeper literature retrieval.*

URLs and publication details (selection)
- Bap31 regulates mitochondrial function via interaction with Tom40 at ER–mitochondria contact sites. Science Advances (2019). https://doi.org/10.1126/sciadv.aaw1386 (accessed for methods and conclusions) (namba2019bap31regulatesmitochondrial pages 2-3).
- Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. American Journal of Human Genetics (2013). https://doi.org/10.1016/j.ajhg.2013.07.023 (cacciagli2013mutationsinbcap31 pages 1-2, cacciagli2013mutationsinbcap31 pages 4-6).
- Schimke XLID syndrome results from a deletion in BCAP31. American Journal of Medical Genetics Part A (2020). https://doi.org/10.1002/ajmg.a.61755 (louie2020schimkexlidsyndrome pages 6-7).
- Bap31 enhances ER export and quality control of human class I MHC. The Journal of Immunology (2006). https://doi.org/10.4049/jimmunol.177.9.6172 (stojanovic2006rolebap31complex pages 26-31).
- Caspase cleavage product of BAP31 induces ER Ca2+-driven mitochondrial fission and sensitizes cytochrome c release. Journal of Cell Biology (2003). https://doi.org/10.1083/jcb.200212059 (stojanovic2006rolebap31complex pages 66-72).
- Bap31 is an itinerant ER protein moving between peripheral ER and a juxtanuclear ERAD-related compartment. Molecular Biology of the Cell (2008). https://doi.org/10.1091/mbc.e07-08-0781 (louie2020schimkexlidsyndrome pages 6-7).

Notes on evidence scope and recency
- We prioritized high-quality mechanistic and clinical sources. Within the current evidence set, 2023–2024 review full-texts specifically discussing Bap31 at MERCs were not retrievable; however, Bap31’s MERC role and disease relevance are strongly supported by Science Advances (2019) and clinical updates through 2020, with consistent mechanistic and phenotypic links (namba2019bap31regulatesmitochondrial pages 2-3, louie2020schimkexlidsyndrome pages 6-7). Where newly published case reports exist beyond these dates, they were outside the retrieved corpus and thus not cited here.

Conclusion
BCAP31 encodes an ER-resident, three-pass membrane chaperone/cargo receptor that integrates ER export and quality control with inter-organellar signaling at ER–mitochondria contacts. Its caspase-regulated signaling role couples death receptor activation to ER Ca2+ mobilization and mitochondrial fission/priming, while its MERC function with Tom40 sustains mitochondrial complex I biogenesis and membrane potential. Loss-of-function variants cause an X-linked neurodevelopmental disorder with deafness, dystonia, and hypomyelination (DDCH/Schimke XLID), accompanied by ER/Golgi disorganization and ERAD defects in patient cells. These convergent functions explain the neurological sensitivity and provide practical handles for diagnosis and mechanistic investigation (stojanovic2006rolebap31complex pages 17-21, stojanovic2006rolebap31complex pages 131-135, stojanovic2006rolebap31complex pages 26-31, stojanovic2006rolebap31complex pages 66-72, namba2019bap31regulatesmitochondrial pages 2-3, cacciagli2013mutationsinbcap31 pages 4-6, cacciagli2013mutationsinbcap31 pages 1-2, louie2020schimkexlidsyndrome pages 6-7).

References

1. (stojanovic2006rolebap31complex pages 17-21): M Stojanovic. Role bap31 complex at the endoplasmic reticulum in normal cell physiology and apoptosis. Unknown journal, 2006.

2. (stojanovic2006rolebap31complex pages 131-135): M Stojanovic. Role bap31 complex at the endoplasmic reticulum in normal cell physiology and apoptosis. Unknown journal, 2006.

3. (louie2020schimkexlidsyndrome pages 6-7): Raymond J. Louie, Debra L. Collins, Michael J. Friez, Cindy Skinner, Charles E. Schwartz, and Roger E. Stevenson. Schimke xlid syndrome results from a deletion in bcap31. American Journal of Medical Genetics Part A, 182:2168-2174, Jul 2020. URL: https://doi.org/10.1002/ajmg.a.61755, doi:10.1002/ajmg.a.61755. This article has 10 citations.

4. (stojanovic2006rolebap31complex pages 66-72): M Stojanovic. Role bap31 complex at the endoplasmic reticulum in normal cell physiology and apoptosis. Unknown journal, 2006.

5. (namba2019bap31regulatesmitochondrial pages 2-3): Takushi Namba. Bap31 regulates mitochondrial function via interaction with tom40 within er-mitochondria contact sites. Science Advances, Jun 2019. URL: https://doi.org/10.1126/sciadv.aaw1386, doi:10.1126/sciadv.aaw1386. This article has 153 citations and is from a highest quality peer-reviewed journal.

6. (cacciagli2013mutationsinbcap31 pages 1-2): Pierre Cacciagli, Julie Sutera-Sardo, Ana Borges-Correia, Jean-Christophe Roux, Imen Dorboz, Jean-Pierre Desvignes, Catherine Badens, Marc Delepine, Mark Lathrop, Pierre Cau, Nicolas Lévy, Nadine Girard, Pierre Sarda, Odile Boespflug-Tanguy, and Laurent Villard. Mutations in bcap31 cause a severe x-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the golgi apparatus. American journal of human genetics, 93 3:579-86, Sep 2013. URL: https://doi.org/10.1016/j.ajhg.2013.07.023, doi:10.1016/j.ajhg.2013.07.023. This article has 79 citations and is from a highest quality peer-reviewed journal.

7. (cacciagli2013mutationsinbcap31 pages 4-6): Pierre Cacciagli, Julie Sutera-Sardo, Ana Borges-Correia, Jean-Christophe Roux, Imen Dorboz, Jean-Pierre Desvignes, Catherine Badens, Marc Delepine, Mark Lathrop, Pierre Cau, Nicolas Lévy, Nadine Girard, Pierre Sarda, Odile Boespflug-Tanguy, and Laurent Villard. Mutations in bcap31 cause a severe x-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the golgi apparatus. American journal of human genetics, 93 3:579-86, Sep 2013. URL: https://doi.org/10.1016/j.ajhg.2013.07.023, doi:10.1016/j.ajhg.2013.07.023. This article has 79 citations and is from a highest quality peer-reviewed journal.

8. (stojanovic2006rolebap31complex pages 26-31): M Stojanovic. Role bap31 complex at the endoplasmic reticulum in normal cell physiology and apoptosis. Unknown journal, 2006.

## Citations

1. louie2020schimkexlidsyndrome pages 6-7
2. https://doi.org/10.1126/sciadv.aaw1386
3. https://doi.org/10.1002/ajmg.a.61755
4. https://doi.org/10.1016/j.ajhg.2013.07.023
5. https://doi.org/10.1083/jcb.200212059
6. https://doi.org/10.4049/jimmunol.177.9.6172
7. https://doi.org/10.1091/mbc.e07-08-0781
8. https://doi.org/10.1002/ajmg.a.61755,
9. https://doi.org/10.1126/sciadv.aaw1386,
10. https://doi.org/10.1016/j.ajhg.2013.07.023,